Molecular Mechanisms of Cetrimonium Bromide Involved in the Epithelial to Mesenchymal Transition of Liver Cancer
童綜合醫學雜誌 · 30.12.2020 · 14 (2) · 55-59
DOI: 10.3966/207135922020121402001 ↗Kurz gefasst
Fachartikel in der Zeitschrift 童綜合醫學雜誌, erschienen am 30.12.2020. Verfasst von Tsai-Kun Wu und 3 weiteren Autor:innen.
Abstract (Originalsprache)
肝癌不論是在腫瘤的發生率或相關致死率皆排名在各類惡性腫瘤的前十名內。由於肝癌的癌化進程快速,導致肝癌患者普遍預後較差。所以研發替代現有的抗癌模式或藥物,以減緩疾病進程顯得刻不容緩。之前的研究顯示,溴化十六烷基三甲銨(cetyltrimethylammonium bromide, CTAB)可經由影響粒線體的凋亡途徑抑制特定癌細胞存活。我們的研究也發現CTAB對不同的肝細胞癌細胞株,例如SK-Hep1,Mahlavu與HA22T/VGH細胞等,在癌細胞的遷移和侵襲方面具有抑制的能力。具體而言,我們發現CTAB分別參與典型和非典型乙型轉化生長因子(transforming growth factor-beta, TGF-β)、成纖維細胞生長因子(fibroblast growth factors, FGF)與酪氨酸蛋白激酶Met(c-Met)/磷脂肌醇-3-激酶(phosphoinositide 3-kinase, PI3K)/蛋白激酶B(Protein kinase B, PKB, also known as Akt)/哺乳動物雷帕黴素靶蛋白(mammalian target of rapamycin, mTOR)等所調控的癌症轉移的關鍵機制-上皮向間質轉換。期能藉由探討CTAB對肝癌的影響模式,深入了解肝癌上皮向間質轉換的相關分子機制,藉此找到抑制肝癌轉移的目標靶點,提供治療肝癌更有效的方法。
Schlagwörter
Zitieren
APA
Wu, T., Yue, C., Pan, Y., & LEE, C. (2020). Molecular Mechanisms of Cetrimonium Bromide Involved in the Epithelial to Mesenchymal Transition of Liver Cancer. 童綜合醫學雜誌, 14(2), 55-59. https://doi.org/10.3966/207135922020121402001
Vancouver
Wu T, Yue C, Pan Y, LEE C. Molecular Mechanisms of Cetrimonium Bromide Involved in the Epithelial to Mesenchymal Transition of Liver Cancer. 童綜合醫學雜誌. 2020;14(2):55-59. doi:10.3966/207135922020121402001
BibTeX
@article{Wu2020,
author = {Wu, Tsai-Kun and Yue, Chia-Herng and Pan, Ying‐Ru and LEE, CHIA-JEN},
title = {Molecular Mechanisms of Cetrimonium Bromide Involved in the Epithelial to Mesenchymal Transition of Liver Cancer},
journal = {童綜合醫學雜誌},
year = {2020},
volume = {14},
number = {2},
pages = {55--59},
doi = {10.3966/207135922020121402001}
}
EUVIMED